Astera Labs (ALAB) EBT (2023 - 2026)

Astera Labs (ALAB) has 4 years of EBT data on file, last reported at $73.4 million in Q1 2026.

• Quarterly EBT rose 238.05% year-over-year to $73.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $269.8 million (up 1225.91% YoY) and the FY2025 annual result came in at $218.2 million, up 366.76% from the prior year.
• EBT retreated to $73.4 million in Q1 2026, from $78.9 million in the prior quarter.
• In the past five years, EBT ranged from a high of $78.9 million in Q4 2025 to a low of -$80.4 million in Q1 2024.
• A 4-year average of $14.4 million and a median of $10.7 million in 2023 frame the typical range for EBT.
• Annual changes were most pronounced in 2024 — EBT plunged 363.98% — and 2025, when it soared 3216.57%.
• Tracing ALAB's EBT over 4 years: stood at $10.7 million in 2023, then climbed by 0.07% to $10.7 million in 2024, then surged by 637.39% to $78.9 million in 2025, then dropped by 6.97% to $73.4 million in 2026.
• The last three EBT figures came in at $73.4 million (Q1 2026), $78.9 million (Q4 2025), and $66.9 million (Q3 2025), per Business Quant data.